Cover image of the article: A comparing Study of Clarithromycin XL with Co-Amoxiclav for Treatment of Chronic Sinusitis; a Clinical Trial

Image Credit:Arch Clin Infect Dis

A comparing Study of Clarithromycin XL with Co-Amoxiclav for Treatment of Chronic Sinusitis; a Clinical Trial

Authors

Maryam Amini1,*, Mohammadebrahim Yarmohammadi2, Pupak Izadi2
1Department of Infectious Diseases and Tropical Medicine, Faculty of Medicine, Shahed University, Tehran, IR Iran
2Department of Otolaryngology (ENT), Faculty of Medicine, Shahed University, Tehran, IR Iran
*Corresponding Author: Department of Infectious Disease, Shaheed Mustafa Khomeini Hospital, Italia Street, Vesal Avenue, Tehran, IR Iran, mmamini55602@gmail.com. Email: mmamini55602@gmail.com

Archives of Clinical Infectious Diseases:Vol. 4, issue 4; 197-201
Published online:Oct 31, 2009
Article type:Research Article
How to Cite:Amini M, Yarmohammadi M, Izadi P. A comparing Study of Clarithromycin XL with Co-Amoxiclav for Treatment of Chronic Sinusitis; a Clinical Trial. Arch Clin Infect Dis. 2009;4(4):. doi:

Abstract

Background:

Chronic sinusitis is one of the most common medical problems affecting 30 million people in USA annually. In the present study, we compared the efficacy and safety of clarithromycin XL and co-amoxiclav on clinical and CT scan findings of patients suffering from chronic sinusitis.

Patients and Methods:

In this clinical trial, a total of 59 subjects (37 males and 22 females, mean age 28 years) with clinical symptoms and CT scan findings of chronic sinusitis were assigned randomly in two groups and treated with clarithromycin XL or coamoxiclav.

Results:

Clinical success rates were similar at the end of therapy period, however, subjects receiving clarithromycin XL showed better CT scan findings when compared with co-amoxiclav-treated subjects (53% versus 29%). Gastrointestinal discomfort was the most frequent treatmentrelated adverse effects in both groups (NS).

Conclusion:

Results revealed that clarithromycin XL and co-amoxiclav have similar efficacy when considered for treatment of chronic sinusitis.

Highlights

Full Text

Full text is available in PDF

Copyright

© 2009, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

31
Jul
2010
A Randomized Controlled Trial of 5-Day Regimen of Azithromycin and a 10-Day Regimen of Co-amoxiclav for Treatment of Acute Sinusitis

A Randomized Controlled Trial of 5-Day Regimen of Azithromycin and a 10-Day Regimen of Co-amoxiclav for Treatment of Acute Sinusitis

Abdolaziz Rastegar Lari,
Alireza Ghaffariyeh,
Noushi Etesam,
Hamid Mostafavi,
Reza Alaghehbandan

Rastegar Lari A, Ghaffariyeh A, Etesam N, Mostafavi H, Alaghehbandan R. A Randomized Controlled Trial of 5-Day Regimen of Azithromycin and a 10-Day Regimen of Co-amoxiclav for Treatment of Acute Sinusitis. Arch Clin Infect Dis. 2010;5(3):. doi:

23
Nov
2019
Nebulized Azithromycin Versus Oral Azithromycin as Anti-Inflammatory Therapy in Children with Cystic Fibrosis: A Prospective Randomized Open-Label Trial

Nebulized Azithromycin Versus Oral Azithromycin as Anti-Inflammatory Therapy in Children with Cystic Fibrosis: A Prospective Randomized Open-Label Trial

Andisheh Maneshi,
Mohammad Reza Modaresi,
Hossein Khalili,
Lida Shojae,
Toktam Faghihi

Maneshi A, Modaresi MR, Khalili H, Shojae L, Faghihi T. Nebulized Azithromycin Versus Oral Azithromycin as Anti-Inflammatory Therapy in Children with Cystic Fibrosis: A Prospective Randomized Open-Label Trial. Inn J Pediatr. 2019;29(6):e96977. doi: https://doi.org/10.5812/ijp.96977

23
Dec
2015
Eradication of Helicobacter pylori in Children by Triple Therapy Regimens of Amoxicillin, Omeprazole, and Clarithromycin or Azithromycin

Eradication of Helicobacter pylori in Children by Triple Therapy Regimens of Amoxicillin, Omeprazole, and Clarithromycin or Azithromycin

Mohammad Reza Esmaeili-Dooki,
Hossein Shirdel,
Mahmood Hajiahmadi

Esmaeili-Dooki MR, Shirdel H, Hajiahmadi M. Eradication of Helicobacter pylori in Children by Triple Therapy Regimens of Amoxicillin, Omeprazole, and Clarithromycin or Azithromycin. Inn J Pediatr. 2015;25(6):e2360. doi: https://doi.org/10.5812/ijp.2360

16
Jan
2016
Formulation and Evaluation of Co-Amoxiclav 228 and 312 mg Dispersible Tablets

Formulation and Evaluation of Co-Amoxiclav 228 and 312 mg Dispersible Tablets

Abolfazl Aslani,
Azam Fathi

Aslani A, Fathi A. Formulation and Evaluation of Co-Amoxiclav 228 and 312 mg Dispersible Tablets. J Rep Pharm Sci. 2016;5(1):e147656. doi:

31
Mar
2013
Rapid High Performance Liquid Chromatographic Method for Determination of Clarithromycin in Human Plasma Using Amperometric Detection: Application in Pharmacokinetic and Bioequivalence Studies

Rapid High Performance Liquid Chromatographic Method for Determination of Clarithromycin in Human Plasma Using Amperometric Detection: Application in Pharmacokinetic and Bioequivalence Studies

Seyed Mohsen Foroutan,
Afshin Zarghi,
Alireza Shafaati,
Babak Madadian,
Farshid Abolfathi

Foroutan SM, Zarghi A, Shafaati A, Madadian B, Abolfathi F. Rapid High Performance Liquid Chromatographic Method for Determination of Clarithromycin in Human Plasma Using Amperometric Detection: Application in Pharmacokinetic and Bioequivalence Studies. Iran J Pharm Res. 2013;12(Suppl):e125604. doi: https://doi.org/10.22037/ijpr.2013.1273

More by these authors

Maryam AminiPubMedScholar
Mohammadebrahim YarmohammadiPubMedScholar
Pupak IzadiPubMedScholar
Share
Cited by
Metrics